Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Bax

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
International Journal of Antimicrobial Agents|November 7, 2007
Development of a twice daily dosing regimen of amoxicillin/clavulanateRichard Bax
Handbook of Experimental Pharmacology|October 24, 2012
Introduction to antibiotic resistanceRichard Bax, David Griffin
The Journal of Antimicrobial Chemotherapy|January 31, 2015
Antibiotics: the changing regulatory and pharmaceutical industry paradigmRichard Bax, Samantha Green
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
Contraception|August 25, 2004
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol IIChristine K Mauck, Debra H Weiner, Mitchell D Creinin, et al.
Contraception|August 25, 2004
Male tolerance study of 1% C31GChristine K Mauck, Ron G Frezieres, Terri L Walsh, et al.
Contraception|August 25, 2004
A phase I comparative postcoital testing study of three concentrations of C31GChristine K Mauck, Mitchell D Creinin, Kurt T Barnhart, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
International Journal of Antimicrobial Agents|November 7, 2007
Development of a twice daily dosing regimen of amoxicillin/clavulanateRichard Bax
Handbook of Experimental Pharmacology|October 24, 2012
Introduction to antibiotic resistanceRichard Bax, David Griffin
The Journal of Antimicrobial Chemotherapy|January 31, 2015
Antibiotics: the changing regulatory and pharmaceutical industry paradigmRichard Bax, Samantha Green
Nature Reviews. Drug Discovery|November 5, 2002
The future challenges facing the development of new antimicrobial drugsAnthony Coates, Yanmin Hu, Richard Bax, et al.
Contraception|August 25, 2004
A randomized Phase I vaginal safety study of three concentrations of C31G vs. Extra Strength Gynol IIChristine K Mauck, Debra H Weiner, Mitchell D Creinin, et al.
Contraception|August 25, 2004
Male tolerance study of 1% C31GChristine K Mauck, Ron G Frezieres, Terri L Walsh, et al.
Contraception|August 25, 2004
A phase I comparative postcoital testing study of three concentrations of C31GChristine K Mauck, Mitchell D Creinin, Kurt T Barnhart, et al.
The Lancet. Infectious Diseases|January 23, 2016
Alternatives to antibiotics-a pipeline portfolio reviewLloyd Czaplewski, Richard Bax, Martha Clokie, et al.
Pageof 1